Back to Search
KENNETH MAHAFFEY, MD
MD
Cardiovascular Disease Physician
NPI: 1659455707IndividualAccepts Medicare
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
96-00991(NC)G129600(CA)
CMS Specialties
PrimaryCARDIOVASCULAR DISEASE (CARDIOLOGY)
Education
UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE
Class of 1989
Research & Publications (20)
Obesity in patients with non-ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.
PMID 19012977·Int J Cardiol·2010
8-other
Integrating ancillary studies in a large clinical trial: the design and rationale of the APEX library.
PMID 18644468·Contemp Clin Trials·2008
8-other
Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial.
PMID 18196350·J Gen Intern Med·2008
4-observational
Creatine kinase-MB elevation after coronary artery bypass grafting surgery in patients with non-ST-segment elevation acute coronary syndromes predict worse outcomes: results from four large clinical trials.
PMID 17267458·Eur Heart J·2007
1-meta
Acute coronary syndromes: what have we learned about what we still need to know?
PMID 16878622·Tex Heart Inst J·2006
8-other
Effect of pexelizumab on mortality in patients with acute myocardial infarction or undergoing coronary artery bypass surgery: a systematic overview.
PMID 16875911·Am Heart J·2006
1-meta
Exploring the role of enoxaparin in the management of high-risk patients with non-ST-elevation acute coronary syndromes: the SYNERGY trial.
PMID 16124952·Am Heart J·2005
8-other
High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial.
PMID 16304073·JAMA·2005
2-rct
Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes.
PMID 15950560·Am J Cardiol·2005
4-observational
The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results.
PMID 14608128·J Invasive Cardiol·2003
8-other
Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial.
PMID 12925455·Circulation·2003
3-trial
Misreporting of myocardial infarction end points: results of adjudication by a central clinical events committee in the PARAGON-B trial. Second Platelet IIb/IIIa Antagonist for the Reduction of Acute Coronary Syndrome Events in a Global Organization Network Trial.
PMID 11835026·Am Heart J·2002
8-other
Anticoagulation for acute coronary syndromes and percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
PMID 11504572·Curr Cardiol Rep·2001
6-review
Systematic adjudication of myocardial infarction end-points in an international clinical trial.
PMID 11806793·Curr Control Trials Cardiovasc Med·2001
8-other
Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT study.
PMID 11806794·Curr Control Trials Cardiovasc Med·2001
8-other
Relationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: results from SYNERGY.
PMID 19406493·Int J Cardiol·2010
4-observational
Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
PMID 19389560·J Am Coll Cardiol·2009
4-observational
Influence of body mass index on the efficacy of revascularization in patients with coronary artery disease.
PMID 19464466·J Thorac Cardiovasc Surg·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 300 PASTEUR DR
STANFORD, CA 94305 - Phone
- (650) 723-4000
Quick Facts
- NPI
- 1659455707
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 37
- Publications
- 20
Are you this provider?
Claim Your Profile